Background-Proinflammatory cytokine tumor necrosis factor-α (TNFα) induces β-adrenergic receptor (βAR) desensitization, but mechanisms proximal to the receptor in contributing to cardiac dysfunction are not known. Methods and Results-Two different proinflammatory transgenic mouse models with cardiac overexpression of myotrophin (a prohypertrophic molecule) or TNFα showed that TNFα alone is sufficient to mediate βAR desensitization as measured by cardiac adenylyl cyclase activity. M-mode echocardiography in these mouse models showed cardiac dysfunction paralleling βAR desensitization independent of sympathetic overdrive. TNFα-mediated βAR desensitization that precedes cardiac dysfunction is associated with selective upregulation of G-protein coupled receptor kinase 2 (GRK2) in both mouse models. In vitro studies in β 2 AR-overexpressing human embryonic kidney 293 cells showed significant βAR desensitization, GRK2 upregulation, and recruitment to the βAR complex following TNFα. Interestingly, inhibition of phosphoinositide 3-kinase abolished GRK2-mediated βAR phosphorylation and GRK2 recruitment on TNFα. Furthermore, TNFα-mediated βAR phosphorylation was not blocked with βAR antagonist propranolol. Additionally, TNFα administration in transgenic mice with cardiac overexpression of G βγ -sequestering peptide βARK-ct could not prevent βAR desensitization or cardiac dysfunction showing that GRK2 recruitment to the βAR is G βγ independent. Small interfering RNA knockdown of GRK2 resulted in the loss of TNFα-mediated βAR phosphorylation. Consistently, cardiomyocytes from mice with cardiac-specific GRK2 ablation normalized the TNFα-mediated loss in contractility, showing that TNFα-induced βAR desensitization is GRK2 dependent. Conclusions-TNFα-induced βAR desensitization is mediated by GRK2 and is independent of G βγ , uncovering a hitherto unknown cross-talk between TNFα and βAR function, providing the underpinnings of inflammation-mediated cardiac dysfunction. (Circulation. 2013;128:377-387.)
levated levels of circulating cytokines are observed in a range of cardiac diseases, including heart failure, myocarditis, and sepsis-induced cardiac dysfunction. 1 Multiple cytokines including tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) are upregulated in conditions of cardiac stress and failure. 1 These cytokines contribute to left ventricular dysfunction and congestive heart failure. 1 It is well known that cytokines influence cardiac mechanical function by altering intrinsic myocyte contractility, and prolonged cytokine exposure leads to cardio-depressant negative inotropic effects. 1 Among the cytokines, strong correlative association is found between TNFα/IL-6 and congestive heart failure. 1 Studies have shown that TNFα mediates negative inotropic effects through immediate and delayed responses. Immediate effects are known to be mediated by altering intracellular Ca 2+ , 2 sphingolipid mediators, 3 and nitric oxide derived from constitutive nitric oxide synthase. 4 Delayed effects are through nitric oxide generated by inducible nitric oxide synthase, reactive oxygen species, and alterations in β-adrenergic receptor (βAR) signaling. 1 βARs are one of the most powerful regulators of cardiac function. 5 βAR downregulation and desensitization (diminished response to catecholamines owing to phosphorylation) are hallmarks of heart failure. 5 Desensitization of βARs in conditions of heart failure is predominantly mediated by G-protein coupled receptor kinase 2 (GRK2, βAR kinase 1 [βARK1]) 5 and is markedly upregulated in conditions of cardiac failure. 6 Indeed, inhibition of GRK2 recruitment to the receptor complex by using GRK2 C-terminal peptide (βARK-ct) ameliorates cardiac dysfunction in mouse models of heart failure. 7 Germline ablation of GRK2 results in embryonic lethality due to intrauterine heart failure. 8 Generation of conditional GRK2 knockout has shown that GRK2 is a critical regulator of βAR desensitization and cardiac function. 8 Cardiac-specific ablation of GRK2 resulted in enhanced basal contractility to acute βAR agonist and, in contrast, has reduced cardiac responses following chronic administration of βAR agonist. 8 Previous studies have shown that GRK2 associates with phosphoinositide 3-kinase gamma (PI3Kγ) in the cytoplasm and recruits PI3Kγ to the βAR complex contributing to receptor internalization. 9 Furthermore, we also have shown that GRK2 and GRK2-associated PI3K activity are significantly elevated in mouse models of heart failure 10 and endstage human heart failure 9 contributing to βAR desensitization and downregulation.
Elevated levels of catecholamine during cardiac stress result in abnormal βAR signaling, in part, because of GRK2-mediated receptor desensitization. 11 Although cytokines cause βAR dysfunction, 1 mechanisms proximal to the receptor in cytokine-induced βAR desensitization are not well understood. To determine the underlying mechanism, we have used transgenic mice with cardiomyocyte-specific overexpression of myotrophin (Myo-Tg, 12 that has elevated TNFα) or TNFα (TNFα-Tg) 13 and show that these mice have significant βAR desensitization even in the absence of sympathetic overdrive. Furthermore, with the use of human embryonic kidney (HEK) 293 cells stably overexpressing FLAG-β 2 AR (HEK-FLAG-β 2 AR), HL-1 cardiac myocytes, and endothelial cells, we show that TNFα alone is sufficient to induce βAR desensitization. Finally, with the use of a combination of transgenic mice with cardiomyocyte-specific overexpression of βARK-ct and cardiac-specific GRK2 knockout mice (GRK2 del), we demonstrate that TNFα-induced βAR desensitization is GRK2 dependent but, importantly, G βγ independent.
Methods

Experimental Animals
Transgenic mice overexpressing myotrophin (Myo-Tg, 12 cardiac TNFα concentration: 4 weeks ≈ 98±17 pg/mL, 8 weeks ≈ 159±37 pg/mL, and 12 weeks ≈ 226±53 pg/mL), TNFα (TNFα-Tg, TNFα ≈ 269±70 pg/mL concentration), 13 or βARK-ct peptide 14 (gift from Dr Walter J. Koch) under the control of α-myosin heavy chain promoter were used for the study. See online-only Data Supplement Methods for GRK2 del mice and TNFR1 (TNFα receptor 1) or TNFR2 knockout mice. 15 Cardiac βAR function in the βARK-ct-Tg was assessed following isoproterenol (ISO, 30 mg/kg per day for 7 days) 16 or TNFα (120 µg/kg per day for 14 days). 17 n represents the number of mice used for the study and shown in figure legends. Animals were handled according to the approved protocols and animal welfare regulation of Institutional Review Board at Cleveland Clinic.
Cell Culture, Treatments, Immunoprecipitation, and Immunoblotting
Standard procedures for cell culture, Western immunoblotting, and immunoprecipitations were followed as described previously 16 (see online-only Data Supplement Methods). HEK 293 cells stably overexpressing FLAG-β 2 AR (HEK-FLAG-β 2 AR) in serum-free media were pretreated for 1 hour with cytokines TGFβ (10 ng/mL), TNFα (10 ng/mL), IL-6 (50 ng/mL), or IL-13 (50 ng/mL). ISO (10 µmol/L) pretreatment was for 30 minutes. Cells were rechallenged with ISO (10 µmol/L) for 5 minutes to measure cAMP generation. Cells were pretreated with propranolol (100 µmol/L for 30 minutes) before TNFα treatment. n represents the number of independent experiments, and each experiment was done in triplicate. Furthermore, endothelial cells or HL-1 myocytes were treated with TNFα (10 ng/ mL) for receptor function analysis (See online-only Data Supplement Methods for culture and treatments).
Confocal Microscopy
Confocal microscopy was performed as previously described. 16 HEK-FLAG-β 2 AR cells were plated onto cover slips and serum starved before ISO or TNFα treatment (see online-only Data Supplement Methods).
Small Interfering RNA Knockdown of GRK2
The 21-mer small interfering RNA (siRNA) duplex 5′-GAAGTAC GAGAAGCTGGAGTT-3′ was used for targeting GRK2. All-Stars negative control siRNA and siRNA against GRK2 were custom made from QIAGEN.
Total cAMP Evaluation
The cAMP content from the clarified extracts was determined according to the manufacturer's instruction by using the Biotrak [ 3 H]cAMP assay system from GE Health Care as previously described or catch point cAMP immunoassay kit (Molecular Devices, Sunnyvale, CA).
16
Purification of Plasma Membrane, Early Endosomes, and Late Endosomes
Purification of plasma membrane and early and late endosomes was performed as previously described 16 (see online-only Data Supplement Methods).
βAR Density and Adenylyl Cyclase Activity βAR density was determined by incubating 20 μg of plasma membranes with 250 pmol of [ 125 I]cyanopindolol alone or along with 40 μmol/L alprenolol for nonspecific binding as previously described. 16 Adenylyl cyclase assays were performed by incubating 20 μg of membranes at 37°C for 15 minutes with isoproterenol or NaF in 50 μL of assay mixture containing 20 mmol/L Tris-HCl, 0.8 mmol/L MgCl 2 , 2 mmol/L ethylenediaminetetraacetic acid, 0.12 mmol/L ATP, 0.05 mmol/L GTP, 0.1 mmol/L cAMP, 2.7 mmol/L phosphoenolpyruvate, 0.05 IU/mL myokinase, 0.01 IU/mL pyruvate kinase, and [γ- 32 P]ATP and generated cAMP was quantified. 16 
Metabolic Labeling and Receptor Phosphorylation
HEK-FLAG-β 2 AR stable cells were starved in phosphate-free media for 2 hours, treated with 100 mCi/mL of 32 P i for 1 hour. Following stimulation, anti-Flag antibody was used for β 2 AR immunoprecipitation from cell lysates, and immunoprecipitates were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. β 2 AR phosphorylation was visualized by autoradiography. 16 
Echocardiography
Echocardiography was performed on lightly sedated mice at respective time points by using a Vevo770 (VisualSonics) echocardiographic machine as previously described.
Determination of Plasma Catecholamine Levels
Plasma levels of catecholamines epinephrine and norepinephrine were measured by using the catecholamine assay kit Bi-CAT EIA ; Alpco Diagnostics), according to the manufacturer's instructions as previously described.
18
Myocyte Isolation and Contractility Studies
The mice were anesthetized; the excised heart was immediately cannulated with a 20-gauge needle, and perfused with collagenase; and contractility studies were performed as previously described. 16 Contractility in the isolated myocytes was assessed by using the IonOptix System (Myopace, Milton, MA) (details in online-only Data Supplement Methods).
Statistical Analysis
Results are expressed as mean±standard error. Data were analyzed by t test for 2-group comparisons (eg, GRK2 densitometric analysis). For comparisons of >2 groups, we used 1-way analysis of variance; if there was 1 independent variable (eg, adenylyl cyclase activity versus percentage of fractional shortening or comparisons across samples for adenylyl cyclase assays or cAMP assays), we used 2-way analysis of variance; if there were 2 independent variables (eg, genotype and treatments as in contractility studies), we used 2-way repeated measures analysis of variance for matched observations over time specifically with the echocardiographic measurements. To adjust for multiple comparisons, we performed Bonferroni correction to evaluate the data. A probability value of P<0.05 was considered significant.
Results
Cardiac Dysfunction and βAR Desensitization in Myo-Tg Mice Is Independent of Sympathetic Overdrive
Echocardiographic and morphometric analysis showed that Myo-Tg mice have progressive cardiac hypertrophy and dysfunction (4-36 weeks) (online-only Data Supplement Figure  IA and online-only Data Supplement Table) . 12 To test whether progressive cardiac dysfunction in Myo-Tg mice alters cardiac βAR function, plasma membrane adenylyl cyclase activity was measured at 4, 8, 12, 16 , and 36 weeks. Progressive loss in adenylyl cyclase activity was observed in Myo-Tg mice from 12 through 36 weeks in comparison with controls (Wt) ( Figure 1A ). Importantly, a direct correlation was observed between adenylyl cyclase activity and cardiac function as measured by fractional shortening ( Figure 1B) . Despite progressive cardiac dysfunction at 4 through 16 weeks in Myo-Tg mice, no alterations of βAR density were observed in plasma membranes, early or late endosomes (online-only Data Supplement Figure IB and IC), except at 36 weeks, wherein βAR distribution was similar to a classical heart failure phenotype (online-only Data Supplement Figure IB and IC).
11
Because sympathetic overdrive is known to cause βAR desensitization in mouse models of heart failure, 19, 20 we tested whether increased plasma epinephrine/norepinephrine levels in Myo-Tg mice could underlie the observed βAR desensitization at 12 weeks. Interestingly, no differences in plasma epinephrine/norepinephrine levels were observed at 8 or 12 weeks in Myo-Tg or Wt mice (Figure 1C and 1D) showing that βAR desensitization is independent of sympathetic overdrive. Thus, βAR desensitization observed at 12 weeks in Myo-Tg mice may be due to elevated inflammatory cytokines. 12 Because GRKs proximally regulate βAR desensitization, we tested whether GRKs are altered in Myo-Tg mice. Significant upregulation of GRK2 was observed in Myo-Tg mice from 12 through 36 weeks in comparison with Wt ( Figure 1E and 1F), whereas other GRKs (GRK 3, 5, and 6) were not altered ( Figure 1E ), suggesting that GRK2 may be the mediator of βAR desensitization in response to inflammatory cytokines. It is well known that inflammatory cytokines mediate βAR dysfunction causing negative inotropy, 1, 2 and Myo-Tg mice have elevated levels of cytokines including TNFα, TGFβ, IL-6, and IL-13 12 that may underlie βAR dysfunction.
TNFα Initiates βAR Desensitization by Upregulating GRK2
To ascertain whether cytokines desensitize βARs, HEK 293 cells stably overexpressing FLAG-β 2 AR (HEK-FLAG-β 2 AR) were pretreated with a combination of cytokines altered in Myo-Tg mice 12 (TNFα, IL-6, IL-13, and TGFβ) (Cyto) and challenged with βAR agonist isoproterenol (ISO) to measure cAMP generation. In addition to observing marked β 2 AR desensitization on ISO pretreatment (Figure 2A ), we also observed significant loss in cAMP generation following pretreatment with Cyto ( Figure 2A ). To assess which of these cytokines mediate β 2 AR desensitization, cells were pretreated with individual cytokines followed by ISO challenge. Significant reduction in cAMP generation was observed on TNFα pretreatment ( Figure 2B ) suggesting that TNFα may be the specific cytokine mediating β 2 AR desensitization. To investigate whether TNFα mediates β 2 AR desensitization via GRKs, HEK-FLAG-β 2 AR cells were treated with individual cytokines TNFα, IL-6, IL-13, or TGFβ and assessed for expression of GRKs. Marked upregulation of GRK2 was observed in cells treated with TNFα with no appreciable .001 versus C. E, FLAG-β 2 AR phosphorylation was visualized by confocal microscopy using antiphospho-β 2 AR antibody (green) following ISO stimulation or TNFα treatment for 5 or 60 minutes. Nucleus was visualized by DAPI (blue) staining. Scale bar: 10 μm. βAR indicates β-adrenergic receptor; DAPI, 4',6-diamidino-2-phenylindole; GRK2, G-protein coupled receptor kinase 2; IL-6, interleukin 6; IL-13, interleukin 13; ISO, isoproterenol; TGFβ, transforming growth factor β; and TNFα, tumor necrosis factor α.
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To test whether TNFα treatment alters receptor phosphorylation, HEK-FLAG-β 2 AR cells were treated with ISO or TNFα, and β 2 AR phosphorylation was assessed by confocal microscopy. Significant β 2 AR phosphorylation (green) was observed after 5 minutes of ISO treatment (positive control) (Figure 2Eb and 2Ej) . Although no β 2 AR phosphorylation was observed by 5 minutes of TNFα (Figure 2Ec and 2Ek ), significant β 2 AR phosphorylation (green) was visualized by 60 minutes (Figure 2Ed and 2El) suggesting that TNFα can mediate βAR phosphorylation. Consistently, significant β 2 AR phosphorylation with no changes in adenylate cyclase expression (online-only Data Supplement Figure ID) was observed in HL-1 cardiac-myoblasts following TNFα.
GRK2 Mediates TNFα-Induced βAR Phosphorylation
To determine the mechanism underlying TNFα-mediated βAR desensitization, plasma membranes from HEK-FLAG-β 2 AR cells were immunoblotted for phospho-β 2 AR and GRK2 on TNFα. Significant recruitment of GRK2 was observed on TNFα ( Figure 3A , bottom) with corresponding increase in β 2 AR phosphorylation as assessed by antiphospho-β 2 AR antibody ( Figure 3A , top). β 2 AR expression was assessed by FLAG immunoblotting ( Figure 3A , middle). To test for recruitment of GRK2 to the βAR complex, FLAG-β 2 ARs were immunoprecipitated from the plasma membranes and immunoblotted for phospho-β 2 AR and coimmunoprecipitating GRK2. Significant GRK2 recruitment to the β 2 AR complex associated with a marked increase in β 2 AR phosphorylation ( Figure 3B , top and bottom) was observed with TNFα. To alternatively test whether TNFα treatment results in β 2 AR phosphorylation, the HEK-FLAG-β 2 AR cells were subjected to metabolic labeling with radiolabeled 32 P i . Following metabolic labeling, the cells were stimulated with TNFα or ISO, and FLAG-β 2 ARs were immunoprecipitated and autoradiography was performed to assess for β 2 AR phosphorylation. Significant β 2 AR phosphorylation was observed on TNFα in comparison with untreated control cells ( Figure 3C , onlineonly Data Supplement Figure IIA ). In addition, mutation analysis of the GRK phosphorylation sites 8, 21 showed significant decrease in TNFα-mediated β 2 AR phosphorylation as shown by metabolic labeling studies ( Figure 3D , online-only Data Supplement Figure IIB) or by the use of antiphospho-β 2 AR antibody (online-only Data Supplement Figure IIC and IID) .
In addition, we further tested the specificity of the antiphospho β 2 AR antibody by using specific blocking peptide. Western immunoblotting showed that blocking peptide completely Figure IIID and IIIE) demonstrating the specificity of the antiphospho-β 2 AR antibody. To assess whether GRK2 mediates TNFα-induced β 2 AR desensitization, GRK2 was depleted by siRNA. Immunoblotting showed significant loss of TNFα-induced β 2 AR phosphorylation ( Figure 3E , top, and 3F) following GRK2 knockdown ( Figure 3E , middle) suggesting that β 2 AR desensitization on TNFα is GRK2 dependent.
Agonist-Independent βAR Desensitization by TNFα
It is well known that GRK2 mediates βAR desensitization in an agonist-dependent manner. 5 To test whether TNFα-mediated βAR desensitization is agonist dependent or independent, cells were pretreated with β-blocker (propranolol) followed by TNFα or ISO to assess β 2 AR phosphorylation by confocal microscopy. Significant β 2 AR phosphorylation was visualized with ISO (green) (Figure 4Ag and 4Ai ) that was abolished with propranolol pretreatment (Figure 4Aj and 4Al) . Despite propranolol pretreatment, β 2 AR phosphorylation was observed with TNFα ( Figure 4Ap and 4Ar) suggesting that TNFα mediates β 2 AR phosphorylation in an agonist-independent manner. Immunoblotting consistently showed significant β 2 AR phosphorylation with TNFα in the presence or absence of propranolol ( Figure 4B , top and bar graph).
Because β 2 AR phosphorylation by GRK2 recruits β-arrestin, 5 we tested whether TNFα recruits β-arrestin to β 2 ARs. HEK 293 cells stably overexpressing β 2 AR and β-arrestin-2-GFP were treated with ISO or TNFα in the presence or absence of propranolol. ISO treatment resulted in significant recruitment of β-arrestin to the β 2 ARs (Figure 4Ca ) that was markedly reduced in presence of propranolol (Figure 4Cb) . Interestingly, we observed β-arrestin recruitment on TNFα in the presence or absence of propranolol (Figure 4Cc and 4Cd) showing that TNFα mediates agonist-independent β 2 AR desensitization through GRK2 and β-arrestin-dependent mechanisms.
GRK2 Recruitment in Response to TNFα Is PI3K Dependent
GRK2 recruitment to the βAR complex can be mediated by either Gβγ subunits of the G protein or through phosphoinositides. 22, 23 To test whether phosphoinositides generated by PI3K could play a role in GRK2 recruitment, HEK-FLAG-β 2 AR cells were treated with TNFα in the presence or absence of LY294002 (selective PI3K inhibitor). A significant increase in β 2 AR phosphorylation and GRK2 recruitment was observed on the plasma membranes following TNFα, which was abolished in the presence of LY294002 ( Figure 5A ). Confocal microscopy on HEK-FLAG-β 2 AR cells showed Figure 4 . TNFα-mediated βAR desensitization is agonist independent. A, FLAG-β 2 AR phosphorylation was visualized by confocal microscopy by using antiphospho-β 2 AR antibody (green) following ISO stimulation or TNFα treatment (60 minutes) in the presence and absence of the β-blocker propranolol. Nucleus was visualized by DAPI (blue) staining. Scale bar: 10 μm. B, Immunoblots of phospho-β 2 AR and FLAG-β 2 AR following TNFα treatment of HEK-FLAG-β 2 AR cells in the presence or absence of propranolol. Densitometric analysis of the same is shown on the lower panel (n=4), *P<0.001 versus Veh, # P<0.001 versus Veh. C, β-Arrestin (green) recruitment to the plasma membrane was visualized by confocal microscopy by using double stable cells expressing GFP-β-Arrestin and HA-β 2 AR following ISO or TNFα in the presence or absence of β-blocker propranolol. Scale bar: 10 μm. βAR indicates β-adrenergic receptor; DAPI, 4',6-diamidino-2-phenylindole; GRK2, G-protein coupled receptor kinase 2; HEK, human embryonic kidney; ISO, isoproterenol; p-β2AR, phospho-β 2 -adrenergic receptor; PROP, propranolol; TNFα, tumor necrosis factor α; and Veh, vehicle.
by guest on November 11, 2017 http://circ.ahajournals.org/ Downloaded from significant β 2 AR phosphorylation on TNFα treatment (green) (Figure 5Ba and 5Bc) which was markedly reduced in the presence of LY294002 (Figure 5Bd and 5Bf) . Because PI3K inhibition reduces GRK2 recruitment and β 2 AR phosphorylation, we assessed whether PI3Kγ is activated in Myo-Tg mice and in cells treated with TNFα. Significant PI3Kγ activation and upregulation was observed in Myo-Tg mice from 12 weeks that overlaps with βAR desensitization (online-only Data Supplement Figure IVA and IVB) . Similarly, PI3Kγ was also upregulated in TNFα-Tg (online-only Data Supplement Figure IVC ). Marked upregulation of PI3Kγ was observed in HEK-FLAG-β 2 AR cells ( Figure 5C ), and significant PI3Kγ activation was observed in HL-1 cardiac-myoblasts following TNFα (online-only Data Supplement Figure IVD) . Together, these studies show that phosphoinositides generated by PI3Kγ regulate GRK2 recruitment to the βAR complex on TNFα.
Cardiac Overexpression of TNFα Results in βAR Desensitization
To test whether TNFα mediates β 2 AR desensitization in vivo we used transgenic mice with myocyte-specific overexpression of TNFα (TNFα-Tg). 13 TNFα-Tg mice have normal cardiac function at 6 weeks that progressively deteriorates to heart failure by 20 weeks. 13 Therefore, cardiac lysates from TNFα-Tg and Wt (6 and 20 weeks) were immunoblotted for GRK 2, 3, 5, or 6. Selective and significant upregulation of GRK2 was observed in the TNFα-Tg mice at both 6 and 20 weeks in comparison with Wt ( Figure 6A , online-only Data Supplement Figure IIIA) with no appreciable differences in GRK 3 or 6 ( Figure 6A ). Interestingly, GRK5 expression was significantly reduced in TNFα-Tg mice in comparison with Wt ( Figure 6A) . Together, these data show that GRK2 is selectively upregulated with TNFα in vivo and may play a role in TNFα-induced βAR dysfunction.
To determine whether β 2 ARs are phosphorylated, immunoblotting was performed on cardiac lysates from TNFα-Tg. Significant β 2 AR phosphorylation was observed at 6 and 20 weeks in TNFα-Tg in comparison with Wt ( Figure 6A) . Analysis of βAR function in TNFα-Tg mice showed a significant loss in adenylyl cyclase activity at 6 and 20 weeks ( Figure 6B ). Furthermore, adenylate cyclase expression was not altered in Figure 5 . PI3K regulates TNFα-mediated GRK2 recruitment to the receptor complex. A, Effect of PI3K inhibition by LY294002 on β 2 AR phosphorylation and GRK2 recruitment to the plasma membrane following TNFα (n=5). B, FLAG-β 2 AR phosphorylation was visualized by confocal microscopy using antiphospho-β 2 AR antibody (green) following TNFα in the presence or absence of PI3K inhibitor LY294002. C, Lysates from HEK-FLAG-β 2 AR cells following TNFα or vehicle treatment were immunoblotted for PI3Kγ (n=4). βAR indicates β-adrenergic receptor; GRK2, G-protein coupled receptor kinase 2; ISO, isoproterenol; LY, LY294002; p-β2AR, phospho-β 2 -adrenergic receptor; PI3K, phosphoinositide 3-kinase; TNFα, tumor necrosis factor α; and Veh, vehicle. Figure 6A ). Despite significant βAR desensitization by 6 weeks in TNFα-Tg, we observed no alterations in βAR density at the plasma membranes of TNFα-Tg or Wt ( Figure 6C ) similar to our observation in Myo-Tg mice (online-only Data Supplement Figure IB) . Furthermore, no differences in epinephrine or norepinephrine levels were observed in TNFα-Tg or Wt ( Figure 6D) showing that the βAR desensitization observed in the TNFα-Tg is independent of sympathetic overdrive.
G β γ -Independent Recruitment of GRK2 Mediates TNFα-Induced βAR Desensitization GRK2 recruitment to the βAR complex is known to be mediated by G βγ subunits. 5 To determine the mechanism of TNFα-induced GRK2 recruitment to the β 2 AR complex, transgenic mice with cardiac-specific overexpression of βARK-ct (βARK-ct-Tg) were administered TNFα or ISO. Measurement of cardiac function by echocardiography showed a significant loss of percent fractional shortening in βARK-ct-Tg and Wt following TNFα treatment ( Figure 7A and 7B). Because significant cardiac dysfunction was observed in βARK-ct-Tg following TNFα, βAR function was assessed by adenylyl cyclase activity. Significant reduction in adenylyl cyclase activity was observed in both βARK-ct-Tg and Wt following TNFα treatment ( Figure 7C ). In contrast, ISO-mediated βAR desensitization was rescued in the βARK-ct-Tg ( Figure 7C ). ISO-mediated β 2 AR phosphorylation was consistently reduced in βARK-ct-Tg ( Figure 7D ). However, TNFα-mediated β 2 AR phosphorylation was not reversed in βARK-ct-Tg ( Figure 7D ), suggesting that GRK2 recruitment to the β 2 AR complex is G βγ independent.
Cardiac-Specific Ablation of GRK2 Rescues Myocyte Contractility
Adult cardiac myocytes were isolated from cardiac-specific GRK2 knockout (GRK2 del) mice and their littermate controls (GRK2 f/f). 8 Following isolation, the myocytes were preincubated with ISO or TNFα and contractility was assessed in the presence of ISO. Marked contractility was observed on ISO in myocytes from GRK2 f/f and GRK2 del mice in the absence of ISO or TNFα pretreatment ( Figure 8A through 8C, black circles, positive control). Myocyte contractility was significantly reduced in GRK2 f/f following pretreatment with ISO or TNFα ( Figure 8A through 8C, green and yellow circles). In contrast, myocyte contractility was rescued in GRK2 del mice despite pretreatment with ISO or TNFα ( Figure 8A through 8C, green and yellow circles) indicating that TNFα-mediated β 2 AR dysfunction is GRK2 dependent.
Differential βAR Phosphorylation by TNFα Receptors
TNFα can mediate its responses through TNFα receptors TNFR1 and TNFR2. 24 To determine the contribution of these receptor subtypes in βAR desensitization, we used aortic endothelial cells that have good representation of βARs from TNFR1 or TNFR2 knockout mice. 25 Significant β 2 AR phosphorylation and GRK2 recruitment to the plasma membrane was observed in endothelial cells from Wt and TNFR1 knockout mice ( Figure 8D , top and middle) that was markedly reduced in TNFR2 knockout mice ( Figure 8D , top and middle) following TNFα. To investigate whether GRK2 is recruited to the TNFα receptor, cardiac TNFR1 or TNFR2 was immunoprecipitated and immunoblotted for coimmunoprecipitating GRK2. Significant levels of GRK2 coimmunoprecipitated with TNFR2 in the Wt or TNFR1 knockout mice ( Figure 8E ). In contrast, we observed reduced coimmunoprecipitation of GRK2 with TNFR1 from Wt or TNFR2 knockout mice ( Figure 8E ). These studies show that TNFR2 may preferentially recruit GRK2 to the plasma membranes. Together our data show that TNFα recruits GRK2 to the plasma membranes in a G βγ -independent manner.
Discussion
In this study, we show that βAR dysfunction is independent of sympathetic overdrive in conditions of inflammation. Furthermore, the observed βAR dysfunction is associated with selective upregulation of GRK2 in 2 proinflammatory mouse models of heart failure (Myo-Tg and TNFα-Tg). Our in vitro and in vivo studies show that TNFα alone is sufficient to induce βAR dysfunction. TNFα treatment of HEK-FLAG-β 2 AR cells or cardiac overexpression of TNFα resulted in marked upregulation of GRK2. Interestingly, TNFα-induced βAR desensitization is agonist independent because βAR phosphorylation is observed despite the presence of the βAR antagonist propranolol. Importantly, TNFα-mediated βAR desensitization is independent of G βγ subunits, because cardiac overexpression of βARK-ct peptide did not rescue βAR dysfunction in response to TNFα. Inhibition of PI3K significantly reduced GRK2 recruitment and β 2 AR phosphorylation on TNFα. Cardiac ablation of GRK2 (GRK2 del) was able to normalize the reduction in myocyte contractility following pretreatment with TNFα. Furthermore, studies from TNFR1 or TNFR2 knockout mice show that TNFR2 preferentially recruits GRK2 mediating β 2 AR phosphorylation. Therefore, our study has identified a cross-talk between TNFα and βAR function that accounts for the reduced cardiac contractility observed in conditions of inflammation.
Elevated inflammatory cytokines are an underlying cause for cardiac dysfunction in patients with congestive heart failure, myocarditis, or sepsis-associated cardiac dysfunction. 1, 26, 27 Accumulating evidence from previous studies [28] [29] [30] and our current study together suggests the presence of a direct cross-talk between the βAR desensitization machinery and upregulated cytokines. Indeed, studies have shown that treatment of neonatal rat myocytes with supernatants from activated immune cells diminished contractility 28 and have identified the cardiacsuppressive components to be TNFα and IL-1. 28 Studies in neonatal myocytes 28 and human airway smooth muscle cells 31 have shown that TNFα predisposes βARs toward decreased G-protein coupling. Although our studies have been limited to TNFα-mediated β 2 AR dysfunction, it is possible that TNFα could similarly mediate β 1 AR desensitization. Consistently, studies have shown that chronic TNFα infusion in rats results in ventricular dysfunction associated with reduced in vitro cardiomyocyte contractility. 32 In this context, we have observed significant βAR desensitization in Myo-Tg or TNFα-Tg mice with cytokine upregulation that is independent of catecholamine overdrive. Correspondingly, our cellular studies show that TNFα alone is sufficient to mediate βAR desensitization. Despite βAR desensitization and cardiac dysfunction, there is no downregulation of plasma membrane receptors in Myo-Tg or TNFα-Tg mice. This is in contrast to catecholamine-mediated βAR dysfunction wherein the βAR desensitization is accompanied with the loss of βARs from the plasma membrane. 10 We speculate that cytokine-mediated βAR desensitization may not robustly recruit subsequent components to dynamically drive receptor internalization, suggesting the presence of different mechanisms yet contributing to cardiac dysfunction.
Despite the knowledge that TNFα could desensitize βARs, little is known about the mechanisms proximal to TNFα-mediated ) treated with Veh or TNFα were immunoblotted for phospho-β 2 AR. The blots were stripped and reprobed for GRK2 and β-actin. E, TNFR1 was immunoprecipitated from cardiac lysates of Wt or TNFR2 −/− mice, and TNFR2 was immunoprecipitated from Wt or TNFR1 −/− mice and immunoblotted for coimmunoprecipitating GRK2 (n=6). F, Illustration depicting mechanism of TNFα-mediated desensitization of βAR through TNFR2 and GRK2. AC indicates adenylyl cyclase; βAR, β-adrenergic receptor; GRK2, G-protein coupled receptor kinase 2; ISO, isoproterenol; p-β2AR, phospho-β 2 -adrenergic receptor; PI3K, phosphoinositide 3-kinase; TNFα, tumor necrosis factor α; TNFR, tumor necrosis factor-α receptor; and Veh, vehicle. by guest on November 11, 2017 http://circ.ahajournals.org/ Downloaded from July 23, 2013 βAR desensitization. Studies using GTPγS loading have shown that TNFα-mediated receptor desensitization is upstream of G-protein coupling. 28 Interestingly, our studies show that TNFα selectively upregulates GRK2 without altering other ubiquitous GRKs ( Figure 6A) . Data from our studies suggest that TNFα mediates βAR dysfunction upstream of G-protein coupling via GRK2 as supported by GRK2 siRNA and conditional cardiac knockout studies. Despite significant increase in GRK2 in response to TNFα, the recruitment of GRK2 to the βAR complex may not be as robust as catecholamine-mediated recruitment. Thus, both sympathetic overdrive and proinflammatory cytokines mediate elevation of GRK2 expression and recruitment to the βAR complex driving phosphorylation and desensitization. Importantly, in vitro and in vivo studies show that TNFα mediates upregulation of GRK2, a molecule proximal to βARs mediating receptor dysfunction.
Our studies show that TNFα-mediated βAR desensitization is agonist independent, because βAR antagonist propranolol did not inhibit β 2 AR phosphorylation or β-arrestin recruitment to the β 2 AR complex on TNFα. This observation suggests that GRK2 recruitment to the βAR complex following TNFα is independent of G-protein activation. Studies in βARK-ct-Tg mice show that cardiac-specific overexpression of βARK-ct could not prevent TNFα-mediated βAR desensitization or cardiac dysfunction, strengthening the idea that GRK2 recruitment to the βARs occurs in a G βγ -independent manner. Studies have shown that GRK2 recruitment to βARs requires both G βγ subunits and phospholipids. 22, 23 Moreover, generated phospholipids are known to regulate GRK2 activity, 22 because mutation of the phospholipid binding site on GRK2 results in the loss of βAR phosphorylation despite the presence of G βγ binding sites. 22, 33 Consistently, inhibition of PI3K resulted in significant loss of β 2 AR phosphorylation and GRK2 recruitment following TNFα, indicating that PI3K activity is required for GRK2 recruitment. Indeed, we have observed increased expression of PI3Kγ in both Myo-Tg (online-only Data Supplement Figure  IVB) and TNFα-Tg mice (online-only Data Supplement Figure  IVC) . We have also observed a significant increase in PI3Kγ activity in Myo-Tg mice, and in HL-1 cardiac myoblasts supporting the role of PI3Kγ in TNFα-βAR cross-talk. Together, these data suggest that GRK2 recruitment to the β 2 AR complex can occur through phospholipid-dependent mechanisms independent of classical G βγ subunits of G proteins.
Although it is known from previous studies, ISO-mediated deleterious cardiac remodeling is ameliorated by the presence TNFR2, 34 it is not known which of the TNFα receptors mediate βAR desensitization. Interestingly, our studies using TNFR1 or TNFR2 knockout mice show that TNFR2 selectively recruits GRK2 in response to TNFα treatment ( Figure 8D and 8E) . Such an observation is intriguing given the beneficial role of TNFR2 in cardiac remodeling. We speculate that the beneficial effects of TNFR2 signaling in the presence of sympathetic overdrive could be through preferential TNFR2-mediated recruitment of GRK2 to mediate βAR desensitization reducing deleterious cardiac signaling and remodeling. Thus, our studies show that TNFR2 may be a key player in regulating the TNFα-GRK2-βAR axis and its effects on cardiac function.
Identification of the TNFα-βAR cross-talk in our current studies has significant implications in obesity, diabetes mellitus, dyslipidemia, and hypertension 35, 36 which are all cardiovascular risk factors with elevated levels of TNFα. Indeed, TNFα is upregulated in all models of obesity and type II diabetes mellitus 37 and, therefore, may lead to upregulation of GRK2 predisposing the heart toward cardiac dysfunction via βAR desensitization. In addition to implications in the cardiovascular axis consistent with our studies, treatment of lung epithelial cells with dexamethasone (an anti-inflammatory agent) resulted in significant inhibition of GRK2 expression. 38 Because asthma is associated with significant inflammatory response accompanied by marked β 2 AR dysfunction, our study suggests that TNFα-GRK2 cross-talk may underlie β 2 AR dysfunction in a proinflammatory milieu. Therefore, our studies are exciting, because they establish a direct signaling pathway linking proinflammatory cytokine TNFα to βAR desensitization via GRK2 (Figure 8F ), providing insights on elevated inflammatory cytokines being secondary to the initiation of cardiac dysfunction and progression of heart failure. 39 
